FindTrial
Sign In

Study on the Impact and Potential Mechanisms of Oral Fecal Microbiota Transplantation Capsules in the Treatment of Helicobacter pylori Infection

Study on the Influence of Fecal Microbiota Transplantation on the Efficacy of Helicobacter pylori Infection Treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118884
Enrollment
Unknown
Registered
2026-02-12
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

FMT plus quadruple therapy :Fecal microbiota transplantation
quadruple therapy alone :Fecal microbiota transplantation

Sponsors

925th Hospital of the Joint Logistic Support Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-65; 2.13C-UBT or biopsy confirmed H. pylori positive; 3.no prior eradication therapy; 4.signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Antibiotics/probiotics within 3 months; 2.previous gastric surgery; 3.IBD; 4.immunodeficiency; 5.pregnancy/lactation. 6.Severe heart, liver, or kidney failure

Design outcomes

Primary

MeasureTime frame
H. pylori eradication rate by 13C-urea breath test;—

Secondary

MeasureTime frame
Gastritis Histology Score (Sydney System, 0-15 points);—

Countries

China

Contacts

Public ContactWei Fu

925th Hospital of the Joint Logistic Support Force

fmmuFW@FOXMAIL.COM+86 1532916170

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026